![Robert Miller](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 42 310 $ al 30/06/2026
Robert Matthew Miller is the founder of Fulcrum Pharma Plc, Artemida Pharma Ltd, and Scancell Holdings Plc.
He is currently the Medical Director at Scancell Holdings Plc, a Member at the American Society of Clinical Oncology, Inc., and a Member at the European Society for Medical Oncology.
Previously, he worked as the Director-Clinical Development at Protodigm Ltd., the Chief Medical Officer at Opsona Therapeutics Ltd., and the Chief Consultancy Physician at Aptiv Solutions, Inc. Dr. Miller holds a doctorate degree from the University of London and The Royal College of Surgeons of England.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
Foresight Enterprise VCT Plc
 Foresight Enterprise VCT Plc Investment ManagersFinance Functions as a private equity fund 0,02 % | 01/06/2026 | 69.000 ( 0,02 % ) | 42 310 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SCANCELL HOLDINGS PLC | Director Técnico/Científico/I+D | 17/11/2020 |
European Society for Medical Oncology
 European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Corporate Officer/Principal | - |
Artemida Pharma Ltd. | Fundador | - |
| Empresas | Cargo | Fin |
|---|---|---|
Aptiv Solutions, Inc.
 Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Corporate Officer/Principal | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Director Técnico/Científico/I+D | - |
Protodigm Ltd. | Corporate Officer/Principal | - |
Fulcrum Pharma Plc
 Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Fundador | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Fulcrum Pharma Plc
Fulcrum Pharma Plc Pharmaceuticals: OtherHealth Technology Provides strategic drug development and regulatory service to the pharmaceutical and biotechnology industries | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services Provides cancer treatment services | Health Services |
European Society for Medical Oncology
European Society for Medical Oncology Medical/Nursing ServicesHealth Services Operates as a medical oncology society | Health Services |
Scancell Holdings Plc
 Scancell Holdings Plc BiotechnologyHealth Technology Develops therapeutic cancer vaccines | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Protodigm Ltd. | |
The Royal College of Surgeons of England
 The Royal College of Surgeons of England Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aptiv Solutions, Inc.
Aptiv Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biological research and development services | Commercial Services |
Artemida Pharma Ltd. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
